Tofacitinib After Live Shingles Vaccination Does Not Impair Immunogenicity Tofacitinib After Live Shingles Vaccination Does Not Impair Immunogenicity

Tofacitinib begun 2 to 3 weeks after live zoster vaccination does not impair immunogenicity, and vaccination appears to be safe in patients with pre-existing varicella-zoster virus (VZV) immunity, researchers report.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology News Source Type: news